Viromed Medical AG (ETR:VME)

Viromed Medical AG Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 9, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	156	77	50	-	-	-
Market Cap Growth	83.64%	53.23%	-	-	-	-
Enterprise Value	156	77	-	-	-	-
Last Close Price	7.35	3.80	2.48	-	-	-
PE Ratio	258.38	127.29	-	-	-	-
PS Ratio	30.70	15.13	44.65	-	-	-
PB Ratio	14.91	7.35	6.95	-	-	-
P/TBV Ratio	19.76	9.73	7.88	-	-	-
EV/Sales Ratio	30.63	15.10	-	-	-	-
Debt / Equity Ratio	0.00	0.00	0.00	-	-	-
Net Debt / Equity Ratio	-0.03	-0.03	0.00	-0.01	-0.01	-1.01
Net Debt / EBITDA Ratio	1.18	1.18	0.00	-	-	-
Asset Turnover	0.37	0.37	0.07	-	-	-
Inventory Turnover	5.15	5.15	-	-	-	-
Quick Ratio	0.71	0.71	0.06	2.33	1.83	-
Current Ratio	4.84	4.84	4.34	2.70	1.87	-
Return on Equity (ROE)	6.83%	6.83%	-22.74%	-0.55%	-1.58%	-
Return on Assets (ROA)	-3.78%	-3.78%	-12.97%	-1.10%	-0.98%	-
Return on Capital Employed (ROCE)	-7.00%	-7.00%	-33.20%	-1.80%	-0.80%	-2.00%
Earnings Yield	0.39%	0.79%	-6.16%	-	-	-
Buyback Yield / Dilution	-4.94%	-4.94%	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 9, 2026

Data Sources Report a data error